Correlation Between Bergenbio ASA and PCI Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bergenbio ASA and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bergenbio ASA and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bergenbio ASA and PCI Biotech Holding, you can compare the effects of market volatilities on Bergenbio ASA and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bergenbio ASA with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bergenbio ASA and PCI Biotech.

Diversification Opportunities for Bergenbio ASA and PCI Biotech

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Bergenbio and PCI is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Bergenbio ASA and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and Bergenbio ASA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bergenbio ASA are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of Bergenbio ASA i.e., Bergenbio ASA and PCI Biotech go up and down completely randomly.

Pair Corralation between Bergenbio ASA and PCI Biotech

Assuming the 90 days trading horizon Bergenbio ASA is expected to generate 1.93 times more return on investment than PCI Biotech. However, Bergenbio ASA is 1.93 times more volatile than PCI Biotech Holding. It trades about 0.02 of its potential returns per unit of risk. PCI Biotech Holding is currently generating about 0.03 per unit of risk. If you would invest  41,874  in Bergenbio ASA on November 27, 2024 and sell it today you would lose (40,854) from holding Bergenbio ASA or give up 97.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Bergenbio ASA  vs.  PCI Biotech Holding

 Performance 
       Timeline  
Bergenbio ASA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bergenbio ASA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
PCI Biotech Holding 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PCI Biotech Holding are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting essential indicators, PCI Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.

Bergenbio ASA and PCI Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bergenbio ASA and PCI Biotech

The main advantage of trading using opposite Bergenbio ASA and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bergenbio ASA position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.
The idea behind Bergenbio ASA and PCI Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance